Skip to main content

Table 3 Activity of levamisole, morantel, and prasterone in the S. ratti model

From: Assessment of FDA-approved drugs against Strongyloides ratti in vitro and in vivo to identify potentially active drugs against strongyloidiasis

Treatment

Dose (mg/kg)

No. of rats cureda/investigated

Mean adult worm burden (SD)

Total adult worm burden reduction (%)

Control 1

No treatment

0/4

148 (13.0)

Control 2

No treatment

0/4

221.25 (81.5)

Control 3

No treatment

0/4

121.3 (15.4)

Levamisole

1001

4/4

0 (0)

100

102

4/4

0 (0)

100

13

4/4

68 (18.5)

43.9

Morantel

1001

3/3

0 (0)

100

102

0/4

66 (8.6)

45.2

Prasterone

1001

0/4

137 (39)

7.6

  1. Superscripts refer to the respective control batch used in the experiment